Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

GOODWILL AND INTANGIBLE ASSETS, NET (Narrative) (Details)

v3.24.1
GOODWILL AND INTANGIBLE ASSETS, NET (Narrative) (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of subsidiaries [line items]      
Amortization expense $ 1,758 $ 2,343 $ 1,158
Goodwill 10,095 9,771  
Amortization expenses from continuing operations $ 1,758    
Adjupharm GmbH ("Adjupharm") [Member]      
Disclosure of subsidiaries [line items]      
Goodwill impairment     $ 275
Trichome Financial Corp. (“Trichome”) [Member]      
Disclosure of subsidiaries [line items]      
Pre-tax discount rate of cash flows 17.50%    
Fixed growth rate 2.00%    
Goodwill   107,854  
Intangible assets impairment   $ 3,067